GCC Medical Device Devices Market

ID: MRFR/MED/42599-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
GCC Medical Device Devices Market Research Report By Device Type Outlook (Drug Delivery System, Diagnostic Devices, Invasive Devices, Respiratory Therapeutic Devices, Electronic Medical Device, Others), By Application Outlook (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, Ophthalmology, General Surgery, Respiratory, Dental, Ear, Nose, and Throat (ENT), Neurology, Nephrology Urology, Others) and By End User Outlook (Hospitals Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) - Growth & Industry Forecast 2025 To 2035
GCC Medical Device Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.37%
2024 Market Size$ 14.29 Billion
2025 Market Size$ 15.3 Billion
2035 Market Size$ 28.2 Billion
Key Players
Medtronic
Abbott Laboratories
Siemens Healthineers
Philips
GE Healthcare
Johnson & Johnson
Trends
  • Technological Advancements in Medical Devices
  • Regulatory Reforms and Market Access
  • Focus on Preventive Healthcare
Opportunities
  • Expansion of Medical Tourism
  • Increasing Healthcare Expenditure
  • Government Initiatives and Support
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Diagnostic Devices
      2. 4.1.2 Therapeutic Devices
      3. 4.1.3 Monitoring Devices
      4. 4.1.4 Surgical Devices
      5. 4.1.5 Rehabilitation Devices
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Clinics
      3. 4.2.3 Home Care
      4. 4.2.4 Ambulatory Surgical Centers
      5. 4.2.5 Diagnostic Laboratories
    3. 4.3 Healthcare, BY Device Type (USD Billion)
      1. 4.3.1 Imaging Devices
      2. 4.3.2 Surgical Instruments
      3. 4.3.3 Patient Monitoring Devices
      4. 4.3.4 In Vitro Diagnostic Devices
      5. 4.3.5 Dental Devices
    4. 4.4 Healthcare, BY Technology (USD Billion)
      1. 4.4.1 Electronics
      2. 4.4.2 Biotechnology
      3. 4.4.3 Nanotechnology
      4. 4.4.4 Robotics
      5. 4.4.5 Materials Science
    5. 4.5 Healthcare, BY Regulatory Classification (USD Billion)
      1. 4.5.1 Class I Devices
      2. 4.5.2 Class II Devices
      3. 4.5.3 Class III Devices
      4. 4.5.4 Combination Devices
      5. 4.5.5 Exempt Devices
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Philips (NL)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 GE Healthcare (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Johnson & Johnson (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun Melsungen AG (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Stryker Corporation (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Boston Scientific (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GCC MARKET ANALYSIS BY APPLICATION
    3. 6.3 GCC MARKET ANALYSIS BY END USE
    4. 6.4 GCC MARKET ANALYSIS BY DEVICE TYPE
    5. 6.5 GCC MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 GCC MARKET ANALYSIS BY REGULATORY CLASSIFICATION
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
      3. 7.2.3 BY DEVICE TYPE, 2026-2035 (USD Billion)
      4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion)
      5. 7.2.5 BY REGULATORY CLASSIFICATION, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

GCC Medical Device Devices Market Segmentation

GCC Medical Device Devices Market By Application (USD Billion, 2026-2035)

  • Diagnostic Devices
  • Therapeutic Devices
  • Monitoring Devices
  • Surgical Devices
  • Rehabilitation Devices

GCC Medical Device Devices Market By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

GCC Medical Device Devices Market By Device Type (USD Billion, 2026-2035)

  • Imaging Devices
  • Surgical Instruments
  • Patient Monitoring Devices
  • In Vitro Diagnostic Devices
  • Dental Devices

GCC Medical Device Devices Market By GCC Medical Device Devices Market (USD Billion, 2026-2035)

  • Electronics
  • Biotechnology
  • Nanotechnology
  • Robotics
  • Materials Science

GCC Medical Device Devices Market By Regulatory Classification (USD Billion, 2026-2035)

  • Class I Devices
  • Class II Devices
  • Class III Devices
  • Combination Devices
  • Exempt Devices

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.